Jaundice (Gilbert's Syndrome) - Causes, Treatment & When to See a Doctor

```html

What is Jaundice (Gilbert’s Syndrome)?

Jaundice is a yellowish discoloration of the skin, sclerae (the whites of the eyes), and mucous membranes that occurs when the level of bilirubin in the blood rises above normal. Gilbert’s syndrome (GS) is a benign, inherited disorder of bilirubin metabolism that is one of the most common causes of intermittent, mild jaundice. It results from a reduced activity of the liver enzyme uridine diphosphate‑glucuronosyltransferase (UGT1A1), which is responsible for converting unconjugated (indirect) bilirubin into a water‑soluble form that can be excreted in the bile.

People with GS typically have normal liver function and no progressive liver disease. The condition is usually discovered incidentally during routine blood work or when a mild jaundice episode follows fasting, illness, or certain medications. While the syndrome itself is harmless, the visible yellowing can cause anxiety, and the underlying enzyme defect can influence how the body handles some drugs.

Common Causes

Gilbert’s syndrome is not caused by external factors; however, the episodic rise in bilirubin can be triggered or mimicked by a variety of other conditions. Below are 8‑10 common causes of jaundice that clinicians consider when evaluating a patient with yellowing skin.

• Hemolysis – accelerated breakdown of red blood cells (e.g., hereditary spherocytosis, sickle cell disease).
• Hepatitis A, B, C or other viral infections – inflammation impairs bilirubin processing.
• Alcoholic liver disease – chronic alcohol intake damages hepatocytes.
• Non‑alcoholic fatty liver disease (NAFLD) – excess fat accumulation leads to impaired bilirubin conjugation.
• Biliary obstruction – gallstones, strictures or tumors block bile flow.
• Drug‑induced liver injury – acetaminophen overdose, certain antibiotics, or antiretrovirals.
• Crigler‑Najjar syndrome – a rare genetic deficiency of UGT1A1 far more severe than GS.
• Pancreatic cancer – can compress the common bile duct, causing obstructive jaundice.
• Sepsis or severe infection – cytokine storm can transiently affect liver function.
• Autoimmune hepatitis – immune‑mediated liver inflammation.

Associated Symptoms

Because GS does not damage the liver, most people experience only the yellow discoloration. Occasionally, they may notice:

• Mild fatigue or a feeling of “being unwell” during a jaundice episode.
• Abdominal discomfort, usually right‑upper‑quadrant, related to fasting or stress.
• Dark urine (due to increased unconjugated bilirubin).
  Note: Dark urine is more typical of conjugated bilirubin; when seen with GS, it usually reflects concurrent dehydration.
• Light‑colored stools (rare, usually indicates another biliary problem).
• Occasional itching (pruritus) – generally mild compared with cholestatic causes.

Most individuals with GS report that episodes are precipitated by:

• Fasting or very low‑calorie diets.
• Strenuous exercise.
• Illness, especially viral infections.
• Dehydration.
• Stressful events.
• Use of certain medications (e.g., oral contraceptives, statins, or irinotecan).

When to See a Doctor

Because Gilbert’s syndrome is harmless, many people never need medical attention. However, you should seek evaluation if you notice any of the following:

• Jaundice that persists for more than a few weeks or worsens despite fasting.
• Severe abdominal pain, especially in the upper right quadrant.
• Persistent dark urine or pale stools.
• Unexplained fever, chills, or rapid weight loss.
• Signs of liver failure such as swelling of the abdomen (ascites), easy bruising, or confusing mental status.
• New medications that cause a sudden jump in bilirubin levels – consult before starting.

These signs may indicate a more serious underlying liver or biliary condition that requires prompt investigation.

Diagnosis

Diagnosing Gilbert’s syndrome involves a combination of clinical assessment and laboratory testing.

1. Detailed History & Physical Examination

• Ask about recent fasting, illness, medication use, and family history of jaundice.
• Observe for yellowing of the skin and sclerae; note that the discoloration is usually uniform and not associated with itching or pain.

2. Blood Tests

• Serum bilirubin – total bilirubin typically 1.0–3.0 mg/dL; mainly unconjugated.
• Liver function panel – ALT, AST, ALP, and GGT are usually within normal limits.
• Complete blood count – rules out hemolysis (look for low hemoglobin, elevated reticulocyte count).
• Coombs test – to exclude autoimmune hemolysis if hemolysis is suspected.

3. Genetic Testing (Optional)

Identification of the common promoter polymorphism (TA)7 in the UGT1A1 gene confirms the diagnosis. Testing is not mandatory unless the diagnosis is uncertain or if the patient is considering medications metabolized by UGT1A1 (e.g., irinotecan).

4. Exclusion of Other Causes

• Abdominal ultrasound or MRCP to rule out gallstones, biliary obstruction, or liver masses.
• Viral hepatitis serologies when recent infection is suspected.
• Autoimmune panels (ANA, SMA) if autoimmune hepatitis is in the differential.

5. Diagnostic Criteria (Simplified)

Most clinicians use the following practical criteria:

1. Unconjugated hyperbilirubinemia < 3 mg/dL.
2. Normal liver enzymes, normal imaging, and no evidence of hemolysis.
3. Symptoms triggered by fasting, stress, or illness.
4. Family history of similar episodes (autosomal recessive inheritance).
5. Optional: Presence of the UGT1A1 (TA)7 promoter polymorphism.

References: Mayo Clinic; NIH genetics resources; Cleveland Clinic.

Treatment Options

Because GS is benign, treatment focuses on symptom relief and avoiding triggers.

Medical Management

• Medication review – discuss with your physician any drugs that may increase bilirubin (e.g., certain antibiotics, oral contraceptives, statins). Dose adjustments or alternatives may be offered.
• Phenobarbital – rarely used; it can increase UGT1A1 activity but is not recommended for routine use because of side‑effects.
• Ursodeoxycholic acid – occasionally prescribed if there is concurrent cholestasis, though evidence for benefit in pure GS is limited.

Home & Lifestyle Strategies

• Maintain regular meals – avoid prolonged fasting; include a modest amount of protein and carbohydrate every 4–5 hours.
• Stay hydrated – adequate water intake helps the liver process bilirubin.
• Limit alcohol – while alcohol does not cause GS, it can worsen overall liver health.
• Balanced exercise – moderate activity is fine; extreme endurance exercise may precipitate jaundice.
• Stress management – techniques such as mindfulness, yoga, or counseling may reduce episode frequency.
• Medication caution – inform pharmacists and providers of your GS diagnosis before starting new drugs, especially chemotherapeutic agents like irinotecan, which rely on UGT1A1 for metabolism.

Prevention Tips

While you cannot eliminate Gilbert’s syndrome, you can minimize episodes:

• Never skip meals for more than 12 hours; incorporate a small snack if you must fast.
• Drink at least 1.5–2 L of water daily, more if you exercise.
• Limit high‑fat, low‑carbohydrate “keto” diets that may increase bilirubin production.
• Avoid excessive alcohol and illicit substances.
• Schedule routine health check‑ups to monitor liver enzymes and bilirubin trends.
• When prescribed medications known to affect bilirubin, discuss dose adjustments or alternative agents with your physician.
• Maintain a healthy weight; obesity can aggravate NAFLD, which can compound jaundice.

Emergency Warning Signs

Key Take‑aways

Gilbert’s syndrome is a common, harmless genetic condition that leads to intermittent unconjugated jaundice. The hallmark is mild yellowing of the skin and eyes that appears after fasting, stress, or illness, while liver enzymes remain normal. Diagnosis is primarily clinical, supported by a characteristic laboratory pattern and, when needed, genetic testing. No specific cure is required; the focus is on lifestyle measures that prevent bilirubin spikes and on awareness of medications that may worsen the condition. Most importantly, patients should be educated about red‑flag symptoms that warrant urgent evaluation, as jaundice can occasionally signal more serious liver or biliary pathology.

For further reading, see:

• Mayo Clinic – Gilbert’s Syndrome
• National Institutes of Health (NIH) – Genetics Home Reference on UGT1A1
• Cleveland Clinic – Jaundice Overview
• World Health Organization – Jaundice Fact Sheet

```